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ABSTRACT 
As of June 30, 1988, 14,299 European cases of acquired immunodeficiency syndrome 
(AIDS) had been reported to  the World Health Organization; 81 percent of these cases 
were diagnosed in France, the Federal Republic of Germany, Italy, the United Kingdom 
and Spain. There were 7,689 homosexual or bisexual cases (54 percent); 3,218 (23 per- 
cent) were intravenous (IV) drug abusers; and 1,043 (7 percent) were heterosexuals who 
had had sexual intercourse with an infected individual. The epidemic started in the early 
19809 among homosexuals and resident of African countries who came to  Europe for 
treatment. AIDS started spreading later, in 1983 and 1984, to  the IV drug abusing com- 
munity in which the epidemic is now spreading faster than in any other group. Short 
term predictions show that by 1989 there may be 56,400 AIDS cases in the European 
Community alone. The World Health Organization estimates that there are approxi- 
mately 480,000 persons in Europe infected with the human immunodeficiency virus (HIV), 
the causative agent of AIDS. The crucial factor concerning the future of the HIV epidem- 
ic remains the extent to which the virus will spread beyond the high-risk groups and into 
the population at  large. It is certain however that given the long incubation period of 
AIDS and the large number of people who are known to be infected, Europe will live 
through a protracted epidemic that will last a t  least another decade or two. 
FOREWORD 
IIASA's Population Program recently started a research activity on the demographic and 
social consequences of the AIDS epidemic. This will encompass the development of an 
AIDS Information and Documentation System (AIkDS), mathematical modelling includ- 
ing the estimation of potential years of life lost through AIDS and the study of behavioral 
and economic consequences. Despite the large international efforts in (mostly medical) 
AIDS research, these questions seem to be a niche that merit further exploration. 
This first Working Paper which was produced in collaboration with Marc Artzrouni, 
Professor a t  Loyola University in New Orleans, gives a brief description of the current 
knowledge on the spread of the infection in Europe. 
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I: BACKGROUND 
The acquired immunodeficiency syndrome (AIDS) is caused by a virus which has be- 
come known as the human immunodeficiency virus (HIV). An individual can become in- 
fected with HIV only through transfers of body fluids during sexual intercourse, through 
blood transfusions, by sharing hypodermic needles with already infected individuals, and 
perinatally, i.e., from an infected mother to her newborn child. The virus can remain dor- 
mant for several years, with the infected person showing few or no symptoms of infection. 
The percentage of infected people who will develop AIDS is still unknown. It was first be- 
lieved that perhaps 10 or 20 percent of infected persons would succumb, but several ongo- 
ing studies suggest that this number may in fact be as high as 100 percent. (Anderson and 
May, 1988). 
There is considerable uncertainty concerning the incubation period of AIDS, i.e., the 
time between exposure to  HIV and the development of full-blown AIDS. The most recent 
studies suggest that the mean incubation period may be about eight years, although it is 
believed to be shorter for children and elderly people (Medley et al, 1987). Because of the 
long incubation period of AIDS, there are currently many more infected individuals than 
there are AIDS cases. It is therefore important to  be able to  assess the prevalence of HIV 
infection, since the pool of infected individuals will gradually move on to  develop AIDS. 
However, surveillance of HIV infection is difficult because most infected people are asymp 
tomatic before they develop AIDS. 
It was long believed that HIV had originated in Africa and then carried to  Europe 
and the United States by immigrants or returning vacationers (Ancelle and Couland, 
1985). However, a growing body of evidence suggests that HIV may have existed since 
the beginning of this century in Africa, Europe, and the United States. Because the 
transmission rates remained below the threshold level at which the epidemic could spread 
widely, the number of individuals with AIDS-like clinical manifestations remained small 
until the 1960s and 19709, a t  which time soci~political changes in Africa and changes in 
life style in the United States and Europe provided fertile grounds for a rapid spread of 
the virus in all regions simultaneously (Wendler, 1986; Katner and Pankey, 1987; 
Chuffart, 1988). 
The World Health Organization (WHO) estimates that between 5 and 10 million 
people worldwide are currently infected with HIV (WHO), 1988a). The first cases of 
AIDS were diagnosed in 1981 among homosexual men in the United States and Europe, as 
well as among residents of Africa and the Caribbeans who came to Europe for treatment 
(Biggar, 1987). As of September 1988 WHO had received 112,000 reports of AIDS cases 
from 176 countries in five continents. The Americans reported the largest number with a 
total of 81,000, of which 71,000 were in the United States. Africa and Europe reported 
about 15,000 cases each, and Asia and Oceania together had less than 1,300 cases (WHO, 
1988d). 
I.: AIDS IN EUROPE 
The surveillance of AIDS in Europe is coordinated by the WHO Collaborating Cen- 
tre on AIDS, created in 1984 in Paris at  Claude Bernard Hospital. The Centre compiles 
standardized surveillance data provided by one nationally recognized source in each of the 
30 participating countries (Ancelle and Brunet, 1987; Ancelle et all 1987). AIDS cases re- 
ported to the Centre meet the surveillance definitions of the Centers for Disease Control 
(CDC) which were established in 1982, and revised in 1985 and 1987 (CDC, 1987a). 
1 .  Aggregate surveillance data 
As of June 30, 1988, a cumulative total of 14,299 cases had been reported from 30 
European countries (Table l)(WHO, 1988~). The five largest European countries 
(France, the Federal Republic of Germany, Italy, the United Kingdom and Spain,) each 
reported more than 1,400 cases, with the largest number in France (4,211 cases). The 
Netherlands (539 cases) and Switzerland (502 cases) have the next largest numbers of 
cases. Only some 80 cases were reported from Eastern Europe, with the largest number in 
Yugoslavia (40 cases). 
A more accurate picture of the spread of AIDS in Europe can be drawn by calculat- 
ing incidence rates per million population (Table 1). Figure 1 depicts incidence rates per 
million population up to  May 1987 and May 1988. (The United States and Canada are 
included as a measure of comparison.) Switzerland (76.1 cases/million) , France (75.7)) 
and Denmark (57.3) have the highest rates. The rates for the Federal Republic of Ger- 
many, Italy, Spain, and the United Kingdom are clustered at lower levels, namely in the 
interval 28 to 38 cases per million inhabitants. 
Within countries there are considerable regional variations in incidence rates of 
AIDS, with much higher rates in more urbanized areas and large cities. The incidence of 
AIDS in the NW Thames Region was more that 15 times that of the Regions of England 
outside the Thames Region (PHLS, 1988). In 1985 the incidence rate of AIDS in the 
Paris region was 84 per million while it was 30 per million for the country as a whole 
(Ancelle-Park et al., 1987). In 1985 Geneva and Ziirich had incidence rates of 62 and 46 
per million, respectively, while the rate for Switzerland as a whole was 6 per million. 
Similar concentrations of AIDS cases are found in the Federal Republic of Germany and 
in Italy (Brunet and Ancelle, 1985)*. 
Trends in incidence rates per million population by half-year of diagnosis provide 
useful information on the temporal dimension of the spread of AIDS. These trends are 
depicted in Figure 2 for the 15 countries with 50 cases or more. The apparent decrease in 
* In October 1988 the incidence of AIDS in Berlin (Weat) waa 264 and in Frankfurt 191 per million while it 
waa 41 per million for the Federal Republic of Germany. 
the incidence rate for the beginning of 1988 is due to the fact that data is available only 
for the first quarter. Also, the incidence rate for recent years (1986 and 1987) is underes- 
timated because of reporting delays. Despite these biases, the picture conveyed by Figure 
2 clearly shows that the number of new AIDS cases is increasing in most countries. 
A more accurate picture of the temporal evolution of AIDS in Europe can be ob- 
tained after correcting the data for reporting delays. These delays vary between country, 
but overall about 10 percent of AIDS cases are reported more than one year after being 
diagnosed (Downs et al., 1988). After correcting for reporting delays Downs et al. have 
estimated the doubling time of the cumulative number of AIDS czmes for the European 
Community, Sweden and Switzerland, which have reported the vast majority of AIDS 
cases in Europe. According to  these estimates the doubling time has been lengthening 
since the beginning of the epidemic from a low of about seven months in 1982 to about 11 
months in 1986. There are however considerable differences between countries, with more 
pronounced decreases of the doubling time in some countries (e.g., Denmark, the Federal 
Republic of Germany, and Switzerland) than in others (e.g., Spain, Austria, and France). 
At the beginning of the epidemic substantial numbers of AIDS patients were non- 
European residents of Africa and the Caribbeans. By March 1985, 156 (17 percent) of the 
940 reported cases were known to be residents from these two regions (Ancelle and Cou- 
land, 1985). By December 1987, when the total number of cases had increased tenfold t o  
9,930, the number of cases from Africa and the Caribbeans had been multiplied by only 3, 
and the totaled 491 cases (5 percent)(Brunet et al., 1988). 
The proportion of non-Europeans varies considerably betwen transmission groups as 
well as through time. By March 1985 there were 126 (70 percent) heterosexual contact 
cases from Africa and the Caribbeans out of a total 179 such cases. By December 1987 
this percentage had decreased to  40 percent, with 241 heterosexual contact cases from 
these regions out of a total of 609. In 1985, there were 13 (2 percent) 
homosexual/bisexual cases from these regions out of a total of 661 such cases and there 
were no IV drug abusers. By December 1987 there were 40 (0.7 percent) 
homosexual/bisexual from these regions out of 5,865 such cases and 21 (1 percent) IV 
drug abusers out of 1,944 total IV drug abusers. In summary, the proportion of non- 
European AIDS cases has decreased over the years, to levels that are negligible among IV 
drug abusers and homosexual/bisexual men, but remain substantial among heterosexual 
contact cases. 
2. Surveillance data by eez and age group 
Of the 13,943 adult cases, 12,415 (89 percent) are male. This high proportion of 
males reflects the large number of homosexual/bisexual men with AIDS. There are 356 
paediatric cases (i.e., children under 13 years of age); 215 (60 percent) of those were male. 
Overall, 86 percent of males cases and 80 percent of female cases were in the 20 to 49 
years age groups. The female cases were highly concentrated in the 20 to  29 years age 
group (51 percent), whereas the maximum concentration of male cases was in the 30 to  39 
years age group (38 percent). 
9. Surveillance data by tranemieeion category 
Of the 14,299 cases of AIDS, 7,689 (54 percent) are male homosexuals or bisexuals, 
3,218 (23 percent) are IV drug users, 1,109 (8 percent) cases are haemophiliacs or transfu- 
sion recipients, 1,043 (7 percent) are heterosexual contact cases, and 264 (2 percent) are 
perinatal cases. There are 337 cases (2 percent) that are both homosexual/bisexual and 
IV drug users, and there are 639 cases (4 percent) with unknown transmission category. 
Although the overall proportion of male cases is about 90 percent, this value is much 
lower in certain risk groups. By June 1988 the percentages of males among IV drug 
abusers, heterosexual contact cases, and transfusion recipients were respectively 74, 64, 
and 59 percent (WHO, 1988~).  
The percentages in each transmission category are broken down by country in Figure 
3. (As a measure of comparison Canada and the United States were added to the 15 Eu- 
ropean countries with the highest incidence of AIDS). The figure shows that there are 
considerable differences between countries in the make-up of the epidemic. As in the Un- 
ited States and Canada, in countries north of France and Switzerland (except Belgium) 
more than 60 percent of cases are homosexual/bisexual. This transmission group 
represents less than 60 percent in France, Belgium, and aouthern Europe. The percentage 
of homosexual/bisexual males varies from a high of 83 percent in the Netherlands to  a low 
of 19 percent in Italy. In all aouthern countries this smaller percentage of 
homosexual/bisexual males corresponds to  a larger group of IV drug abusers. The percen- 
tage of IV drug abusers is as low as 6 and 2 percent in the Netherlands and the United 
Kingdom, respectively, and as high as 63 percent and 58 percent in Italy and Spain. 
There are variations between countries in the percent of heterosexual contact cases. 
Of the 15 countries with the highest caseloads, only three report more than 10 percent of 
cases as heterosexual: Portugal and Greece both have 18 percent, and Belgium is an 
outlier with 53 percent. This high percentage is due to  the fact that 59 percent of cases 
diagnosed in Belgium were among expatriates and foreigners who had lived in the country 
less than 5 years and had gone to  Belgium for treatment following their exposure to  AIDS 
through heterosexual contact in Africa (IHE, 1988). 
An examination of temporal trends in the breakdown of AIDS cases by transmission 
group sheds light on the dynamics of the epidemic. The first cases were reported in the 
early 1980s in homosexual/bisexual men and in heterosexuals; most patients in this latter 
group were diagnosed in Belgium and in France and had contracted the disease through 
heterosexual contact in African and Caribbean countries where AIDS was developing out- 
side the main risk groups. In Belgium, for example, the percentage of cases among non- 
residents was 97 percent in 1983, but fell rapidly thereafter. (Brunet et al., 1988; Ancelle 
and Couland, 1985; Downs et al., 1987). 
The outbreak in the early 1980s of a homosexual epidemic in France, the Federal 
Republic of Germany, and the United Kingdom, and the concurrent outbreak of a 
heterosexual epidemic in France and Belgium were followed in the mid-1980s by the emer- 
gence of an AIDS epidemic of IV drug abusers. This later epidemic affected Italy and 
Spain first, then the Federal Republic of Germany, France, and to a lesser extent Switzer- 
land. 
The shifts in the epidemiologic make-up of AIDS in Europe can be measured by not- 
ing that in 1983, 164 cases (61 percent) were diagnosed in homosexual/bisexual men, and 
57 cases (21 percent) were diagnosed in heterosexuals. That same year there were only 4 
cases (1 percent) among IV drug abusers. In 1987, however, the proportion of AIDS cases 
among homosexual/bisexual men and among heterosexuals had dropped respectively by 
10 and 15 percent to 51 and 6 percent of cases diagnosed during that year (Figure 4). The 
25 percent of cases lost in these two groups were found among IV drug abusers, whose 
share had risen from 1 to 26 percent. These statistics confirm that the epidemic among 
IV drug abusers is more recent than in homosexual/bisexual men and that its growth has 
also been more rapid than in the other groups. 
The relatively rapid increase in the number of IV drug abusers with AIDS has 
caused the mean age of AIDS patients to  decline and the proportion of women patients to  
increase: the proportion of AIDS patients under 30 has increased from 20 to  34 percent 
and the sex ratio has dropped from 11.7 men for each woman to  7.6 (Brunet et al., 1988; 
WHO, 1988~).  These shifts can be explained by the fact that IV drug abusers tend to  be 
young, and that their growing number mitigates the weight of the all-male group of 
homosexual/bisexual men. 
III: HIV IN EUROPE 
As indicated earlier there is no accurate and complete data on the total number of 
people infected with HIV because most infected individuals remain asymptomatic until 
they develop AIDS. However, WHO haa compiled rough estimates of the prevalence of 
HIV infection in Europe on the basis of information provided by individual countries 
(Table 2). The table first gives the numbers of known seropositive individuals, i.e., the 
number of individuals who have tested positive for the HIV antibody. (These data are 
based on laboratory reports or tests performed on donated blood). These estimates 
represent minimum levels of HIV prevalence, since it is known that there are many more 
infected individuals who have not yet been tested. 
The table also presents maximum, minimum, and best estimates of HIV prevalence 
in each European country. The best estimates for the total number of infected individuals 
in Europe is in the 470,000 to 480,000 range. This number can be compared to the official 
estimate of 1 to  1.5 million infected individuals in the United States (CDC, 1987b). It 
should be emphasized that in both cawa these are merely orders of magnitude that are 
subject to revision as additional data become available. 
The presence of HIV in the body is determined indirectly by testing blood for the 
presence of serum antibodies against the virus. Seropositivity tests are now routinely 
used to test for HIV infection in selected groups (blood donors, IV drug abusers, persons 
attending sexually transmitted disease clinics, prostitutes, etc.) In one large scale study 
drawing data from 11 European countries, 10,301 individuals were tested during the years 
1981-1984 (Ebbesen et al., 1986). The following groups were represented in the study: 
healthy male homosexuals, patients with AIDS, IV drug abusers, hemophiliacs, and non- 
risk group members. 
The data showed an increase in seropositivity in high-risk groups that paralleled the 
growth in the number of AIDS cases. For example the percent infected with HIV among 
Italian male homosexuals rose from 1 percent in 1981 to 19 percent in 1984. Among Swiss 
IV drug abusers the percent rose from 0 percent to 46 percent. 
Several countries have conducted seroprevalence studies among specific groups. Be- 
cause of differences in the study designs results cannot easily be compared, even within a 
given risk group and for the same country. However, the results provide orders of magni- 
tude and are useful in comparing the prevalence of HIV in different risk groups. The 
results of a number of studies are presented in Table 3 and Figure 5. For the 20 studies 
conducted with IV drug abusers the percent infected varied from 0 percent (in Bern, 
19741981) to 71 percent among Italian prostitutes in 1984. The median was 35.5 per- 
cent. Six studies among homosexuals produced percentages between 10 and 31 percent. 
Among blood donors the percentage was 0.2 percent in one German study and less than 
0.1 percent in large scale screenings in France, Spain, and the United Kingdom. 
The overall picture is that of an infection that has already spread significantly in the 
homosexual and IV drug abusing communities. The much lower incidence rates found 
among blood donors reflect the fact that HIV is spreading more slowly in the population 
at  large. 
N: SHORT-TERM PREDICTIONS 
The WHO Collaborating Centre on AIDS does short-term predictions of AIDS in 
Europe based on an exponential model that assumes a constant growth rate over a period 
of two years (i.e., a doubling time that remains constant) (Downs et al., 1987; Downs et  
al., 1988). In view of the declining trend in the doubling time, such predictions are be- 
lieved to provide upper bounds to  the number of AIDS cases over the next two years. 
The results of WHO'S predictions for 12 countries plus the European Community as a 
whole are presented in Table 4. The baseline period is December 31, 1987, and the 
number of predicted AIDS cases in 1988 and 1989 is given for each country and the Eur* 
pean Community. 
France is expected to have the largest number of cases with 21,101 AIDS cases by 
the end of 1989. Four countries are predicted to  have a cumulative total between 6,000 
and 12,000 cases (Italy, the Federal Republic of Germany, Spain, and the United King- 
dom). Austria, Belgium, Denmark, Greece, the Netherlands, Norway and Switzerland are 
expected to  have less than 1,700 cmes. The predicted total for the European Community 
is 56,400. 
V: DISCUSSION 
With a total of 14,299 AIDS cases to  date, Europe is confronted with a serious epi- 
demic that has made significant inroads in the high-risk groups of homosexual/bisexual 
men and IV drug abusers. 
Although the basic modes of transmission of HIV are the same for all countries, 
there are considerable differences between countries in the make-up of the epidemic. In 
northern Europe the majority of cases are found in homosexual men, whereas in southern 
Europe the epidemic has affected primarily IV drug abusers. In Belgium, the same virus 
was introduced by heterosexual patients who had contracted the disease in Africa. These 
variations reflect differences in life styles, in degrees of acceptance of these life styles, and 
also in the timing and the history of the epidemic. For example, in one country HIV may 
have taken hold first among IV drug abusers, then penetrated the homosexual community 
through a "bridge" of homosexual IV drug abusers. In another country the virus may 
have penetrated the homosexual community first, and only later affected IV drug abusers. 
To date, the virus has not spread much beyond these high-risk groups (and their sexual 
partners) because transmission of the virus is truly efficient only through the sharing of 
needles and through sexual intercourse, particularly between homosexual men. 
The future course of the HIV epidemic depends crucially on the extent to  which HIV 
will spread in the heterosexual population. This spread will depend on whether the 
heterosexual cases will remain primary infections contracted directly from individuals in 
high-risk groups, in which case the heterosexual epidemic will run its course once HIV has 
saturated these high-risk groups. There is some evidence to suggest that this may be oc- 
curing. Rates of new infections among homosexuals are stabilizing and the numbers of 
new AIDS cases may soon be leveling off in some countries (e.g., the United Kingdom 
(PHLS, 1988); Brunet et al., 1988). 
If on the contrary the epidemic sustains itself among non-drug abusing heterosexu- 
als, with even a slow, drawn-out increase aa suggested by Anderson and May (1988), then 
Europe (w well as the United States) is faced with the prospect of a major epidemic that 
would have profound social, economic, political, and ethical implications. 
Europe is now at  a critical point in its fight against the spread of HIV. Indeed, it is 
too soon to  predict which scenario will play itself out, but the answer could come in two 
or three years. Although few things are known with certainty concerning the future 
course of AIDS in Europe, we do know that there is a large pool of infected individuals 
who will come down with AIDS for a t  least another decade or two. We will therefore wit- 
ness a protracted epidemic, whose impact can however be mitigated through education 
campaigns, counseling of IV drug abusers, and a compaesionate approach to  those afflicted 
with AIDS. 
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TABLE 1 
Cumulative AIDS cases reported by 30 European countries and 
estimated cumulative incidence rates per million population 
31 June, 1988 
- - 
COUNTRY A I D S  Cases Rates per million 
population 
Albania 
Ausma 
Belgium 
Bulgaria 
Czechoslovakia 
Denmark 
Finland 
France 
German, Dem. Rep. 
Germany, Fed. Rep. 
Greece 
Hungary 
Iceland 
Ireland 
Israel 
Italy 
Luxembourg 
Malta 
Netherlands 
Norway 
Poland 
Portugal 
Romania 
S an Marino 
Spain 
Sweden 
Switzerland 
United Kingdom 
USSR 
Yugoslavia 
TOTAL 14,299 18.4* 
Source: WHO (1988~). 
* The overall rate is 28.5 if the USSR, which has only 3 cases, 
is excluded. 
TABLE 2 
Estimated prevalence of HIV infection 
January 1988 
COUNTRY Number of Estimated   re valence of HTV infection (in thousands) 
known infectives Maximum Minimum Best estimate 
A1 bania 
Ausma 
Belgium 
Bulgaria 
Czechoslovakia 
Denmark 
Finland 
France 
German, Dem. Rep. 
Germany, Fed. Rep. 
Greece 
Hungary 
Iceland 
Ireland 
Israel 
Italy 
Luxembourg 
Ma1 ta 
Monaco 
Netherlands 
Norway 
Poland 
Porrugal 
Romania 
San Marino 
Spain 
Sweden 
Switzerland 
United Kingdom 
USSR 
Yugoslavia 
TOTAL >57,74 1 800,000 280,000 480,000 
Source: WHO Strbske Pleso Meeting (Czechoslovakia). February 1988. 
TABLE 3 
Prevalence of serum antibodies againt HIIN, selected studies. 
Country 
Reference 
Size, Population (Year) % with HIV 
antibodies 
Austria 
(Fuchs er al, 1985) 
Denmark 
(Kolby er al., 1986) 
34 imprisoned drug users (1985) 44 
737 persons at AIDS screening clinics 
homosexuals 36 
bisexuals 14 
heterosexuals 4 
females 4 
Fed. Rep. of Germany 
(Schneider er al, 1986) 6,720 blood donors (1984) 
France 
(Brenky-Faudeux and 50 prostitutes 0 
and Fribourg-blanc, 1985) 
Petithory er al, 1986) 100 N drug abusers (Sept. 85-March 86) 5 1 
(Ancelle er al, 1987) 4,100,000 blood donors (1986) 0.042 
(DGS, 1987) 5,719 pregnant women (1987) - 3
Greece 
(Papaevengelou er al, 1985) 200 registered prostitutes (1985) 6 
10,000 blood donors (1985) 0 
Italy 
(Ferroni er al., 1985) 153 IV drug abusers (1979-1981) 
265 IV drug abusers (1982- 1983) 
271 IV drug abusers (1984-1985) 
(Tirelli er al, 1985) 24 IV drug abusing prostitutes 
38 non dnlg abusing prostitutes 
95 male IV drug abusers 
30 homosexuals 
(Luzi er al., 1987) 18,000 IV drug abusers 
in northern Italy 
in central Itlay 
in soilthem Italy 
Netherlands 
(Cramer, 1986) 145 IV drug abusers (1983-1984)) 3.4 
52 addicted prostitutes 2 3 
(van Griensven, 1987) 741 healthy homosexuals (Oct. 84-May 55) 31 
Spain 
(WHO, 1986) 538 IV drug abusers (1985) 
226 homosexual and bisexual, men 
297 hemophiliacs 
5 children of seropositive women 
(Andres Medina, 1988) 150,000 blood donors (1986) 
300,000 blood donors (1987) 
Switzerland 
(Schupbach er al, 1985) 103 IV drug abusers, Zurich (1984) 
40 healthy homosexual men 
(Mortimer er al, 1985) 93 IV drug abusers, Bern (1979-1981) 
128 IV drug abusers, Bern (1982-1983) 
75 IV drug abusers, Bern (1984-1985) 
United Kingdom 
(Gunson and Rawlinson. 1988) 5.840.520 b1ood:donors (Oct 85- Dec 57) 
(~obertson er al, 1986) ' 1'64 IV drug abusers, Edinburgh (1986) 
(Follert er al., 1986) 606 IV drug abusers, Glasgow (1985) 
(Jesson, 1986) 4,035 healthy homosexuals 
1,847 hemophiliacs 
239 IV drug abusers 
TABLE 4 
PREDICTED CASES OF AIDS TO DECEMBER 1989: A U  RISK GROUPS COMBINED 
Cases diagnosed Estimated Cumulated cases projected 
up to 31 Dec 87 current to be diagnosed by: 
cou'JluY - - - - - - - - - - - - - - -  doubling . . . . . . . . . . . . . . . . . . . . . .  
Rep.' ~ d j . ~  time 31 Dec 88 31 Dec 89 
(months) 
Austria 139 
Belgium # 126 
Denmark 22 8 
France 3073 
F.R. Germany 1669 
Greece 88 
Italy 1411 
Netherlands 420 
Norway 70 
Portugal 90 
Spain 789 
Sweden 163 
Switzerland 355 
United Kingdom 1 227 
E.C. ## 91 64 
1 : as reported by 31 Dec 1987 
2: as estimated ("adjusted") to allow for delays in reporting 
3: estimated by fitting an exponential model to (adjusted) cases diagnosed over the last 3 years 
4: obtained by extrapolation using the estimated current doubling time 
# residents only (Belgium) ## European Community (model using pooled data) 
' 0.801 R2 c 0.90, 0.701 R2 c 0.80 "' R~ < 0.70 (in all other cases, R2 2 0.90) 
Source: Downs e t  al, 1988 
Cases of AIDS (Cumulative) per 1 Mio. of Population 
for Selected European Countries, the United States 
of America and Canada, May 1987 and May 1988 
United States 
Switzerland 
Canada 
France 
Denmark 
Belgium 
Netherlands 
Italy 
Spain 
United 
Kingdom 
Austria 
Sweden 
Norway 
Portugal 
Greece 
Source: WHO: Graphic: AILDS: IIASA2. (c) Heilig (22.7.88) 
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